	自己資本および準備金		日付
AbbVie	USD -5.94B	721M	2026-06
Amgen	USD 11.69B	2.5B	2026-06
Anika Therapeutics	USD 137.28M	3.38M	2026-06
Arrowhead Research	USD 465.53M	148.45M	2026-06
AstraZeneca	USD 50.3B	2.96B	2026-06
BioCryst Pharmaceuticals	USD -454.29M	99.55M	2026-06
Biogen	USD 18.85B	196.3M	2026-06
Bristol-Myers Squibb	USD 22.32B	2.25B	2026-06
Enanta Pharmaceuticals	USD 126.59M	61.87M	2025-12
Gilead Sciences	USD 11.74B	11.77B	2026-06
GlaxoSmithKline	GBP 17.64B	223M	2026-06
Halozyme Therapeutics	USD 143.54M	76.09M	2026-06
Heron Therapeutics	USD 6.91M	2.23M	2026-06
Immunic	USD 151.23M	157.91M	2026-03
Incyte	USD 6.34B	721.58M	2026-06
Insmed	USD 757.49M	52.64M	2026-06
Ionis Pharmaceuticals	USD 439.74M	51.68M	2026-06
J&J	USD 84.97B	3.78B	2026-06
Karyopharm Therapeutics	USD -265.65M	27.28M	2026-03
Ligand Pharmaceuticals	USD 967.52M	29.81M	2026-06
Merck	USD 41.93B	3.94B	2026-06
Neurocrine Biosciences	USD 3.69B	286.2M	2026-06
Novartis	USD 41.95B	3.02B	2026-06
Novavax	USD -190.71M	45.94M	2026-06
Pfizer	USD 85.19B	4.91B	2026-06
PTC Therapeutics	USD -165.36M	15.1M	2026-06
Roche Holding	CHF 32.69B	1.11B	2026-06
Sarepta Therapeutics	USD 1.53B	22.7M	2026-06
Vertex Pharmaceuticals	USD 20.25B	886M	2026-06